Medibank Pvt (ASX:MPL) GF Value Rank: 5 (As of Jul. 05, 2026) — 17% Below Median


ASX:MPL Medibank Pvt Ltd ASX:MPL
77 GF Score
Price A$5.00
GF Value A$4.39
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Medibank Pvt GF Value Rank?

Medibank Pvt ASX:MPL +0.20% 77 GF Value Rank is 5 as of Jul. 05, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates ASX:MPL with a GF Score™ of 77/100 and a GF Value™ of A$4.39 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Medibank Pvt has the GF Value Rank of 5.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Medibank Pvt GF Value Rank Related Terms

ASX:MPL vs FNF, AXS, FAF: GF Value Rank Comparison

For the Insurance - Specialty subindustry, Medibank Pvt's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medibank Pvt GF Value Rank vs Insurance Industry

For the Insurance industry and Financial Services sector, Medibank Pvt's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Medibank Pvt's GF Value Rank falls into.


ASX:MPL
77GF Score
Medibank Pvt Ltd ASX:MPL
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 5 mean?
Medibank Pvt (ASX:MPL) has a GF Value Rank of 5 as of Jul. 05, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Medibank Pvt and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Medibank Pvt's GF Value Rank has ranged from 3.00 to 9.00.
Is Medibank Pvt's GF Value Rank too high?
Medibank Pvt's current GF Value Rank of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 9.00. Overall, Medibank Pvt has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's GF Value Rank compare to FNF and AXS?
Medibank Pvt's GF Value Rank of 5 can be compared against companies in the Insurance industry. Historically, Medibank Pvt's own GF Value Rank has ranged from 3.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for an Insurance company?
A good GF Value Rank depends on the Insurance industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Medibank Pvt and its competitors. Medibank Pvt's current GF Value Rank is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.39, compared to a current price of A$5.00 — trading 13.9% above its estimated fair value. The current GF Value Rank is 5, which is 17% below median its 10-year median of 6.00. Medibank Pvt's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current GF Value Rank is 5 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medibank Pvt (ASX:MPL) Overvalued in 2026?

Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued. The current stock price of A$5.00 is trading 13.9% above its estimated GF Value™ of A$4.39. GuruFocus considers Medibank Pvt to be Modestly Overvalued.

Key valuation signals for ASX:MPL:

  • GF Value Rank: 5 (17% below median its 10-year median of 6.00)
  • GF Value™: A$4.39 vs. price of A$5.00 (13.9% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medibank Pvt Business Description

Other Exchanges MDBPF:USAMDBKY:USA
Address 695 Collins Street, Medibank Melbourne Hub, Level 2, Docklands, Melbourne, VIC, AUS, 3008
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
77GF Score

Get the complete analysis for ASX:MPL

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$5.00
Price
A$4.39
GF Value